Since it has been shown that loss of CDK8 protein but not inhibition of its enzymatic activity is cytotoxic for BCR­ABL1+ B-ALL [37], we assessed the sensitivity of NALM-­6 and RS4;11 cells to the CDK8 inhibitor SEL120. The gene discussed is CDK8; the disease is acute lymphoblastic leukemia.